Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study

BACKGROUND: Pirfenidone is an anti-fibrotic agent shown to slow the progression of idiopathic pulmonary fibrosis (IPF). However, its effectiveness in association with serological autoimmune features in IPF remains unclear. METHODS: We retrospectively reviewed the medical records of patients with IPF...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Pulm Med
Main Authors: Song, Myung Jin, Lee, Sang Hoon, Jung, Ji Ye, Kang, Young Ae, Park, Moo Suk, Kim, Young Sam, Chang, Joon, Kim, Song Yee
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8091553/
https://ncbi.nlm.nih.gov/pubmed/33941141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-021-01516-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki